Bayer pledges $300M to boost production in world’s ‘contraceptive capital’

Bayer, currently in the midst of a gung-ho cell therapy expansion in the U.S., is turning its attention back to Europe as it looks to beef up its birth control manufacturing in the world’s “contraceptive capital.” The company has designs on a €250 million ($303 million) investment for a new production plant in Turku, Finland, which […]

AZ, Pfizer/BioNTech vaccines ‘highly effective’ against Delta variant

AstraZeneca and Pfizer/BioNTech’s COVID-19 vaccines are ‘highly effective’ at protecting against the Delta (previously known as the Indian) variant, according to new real-world data from Public Health England (PHE). The analysis included 14,019 cases of the Delta variant, of which 166 were hospitalised, between 12 April and 4 June, looking at emergency hospital admissions in […]

Opdivo plus Yervoy scores NICE backing for certain bowel cancer patients

Bristol Myers Squibb’s (BMS) immunotherapy combination Opdivo plus Yervoy has been recommended by the National Institute for Health and Care Excellence (NICE) for the treatment of certain advanced bowel cancer patients. In its final appraisal document (FAD), NICE has recommended Opdivo (nivolumab) plus Yervoy (ipilimumab) for advanced bowel cancer patients with the rare high microsatellite […]

Nemera breaks ground in Brazil through Milfra acquisition


With this acquisition, Nemera establishes an operational footprint in Brazil and expands its product and services offering to better serve the pharmaceutical industry in Latin America. Nemera today announced that they have entered into an agreement to acquire Milfra. Milfra, based in Jaguariuna, state of São Paulo, Brazil, specializes in the development and production of […]